Biogen Idec, which employs about 850 people in Research Triangle Park, is seeking a new top executive.
James Mullen, 51, who has been the Massachusetts company's CEO since 2000, plans to retire June 8. He joined Biogen in 1989.
"Jim Mullen's more than 20years of leadership have transformed Biogen Idec from a fledgling company with no marketed products to a global leader in the biotech industry," chairman William Young said in a prepared statement.
Biogen is the world's largest maker of multiple sclerosis drugs. The company manufactures two MS treatments, Avonex and Tysabri, at its 175-acre RTP campus; it also handles patient support services. The company established the site in 1995.
Staff writer Alan M. Wolf
Get the biggest news in your email or cellphone as it's happening. Sign up for breaking news alerts.
The next successor in Apple's iPad tablet may be unveiled soon and with significant hardware upgrades. 
The 1991 background check was conducted when then-President George H.W. Bush was considering Steve Jobs for a spot on the President's Export Council, a position he did not get. 
Eastman Kodak Co. said Thursday that it will stop making digital cameras, pocket video cameras and digital picture frames, marking the end of an era for the company that brought photography to the masses more than a century ago. 
Parenting can be tough. When Tommy Jordan discovered a disrespectful FaceBook post from his 15-year-old daughter he decided to get tough. Not only did Jordan fight fire with fire in a public video address to his daughter, he fired nine rounds into his daughters laptop. Keep up with the latest business stories with our free e-mail newsletter, delivered straight to your inbox!
Subscribe to Business - it's free!
Subscribe to NC Business News - it's free!
Subscribe to Technology/Biotech - it's free!
